Your browser doesn't support javascript.
loading
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Mansouri, Larry; Thorvaldsdottir, Birna; Sutton, Lesley-Ann; Karakatsoulis, Georgios; Meggendorfer, Manja; Parker, Helen; Nadeu, Ferran; Brieghel, Christian; Laidou, Stamatia; Moia, Riccardo; Rossi, Davide; Catherwood, Mark; Kotaskova, Jana; Delgado, Julio; Rodríguez-Vicente, Ana E; Benito, Rocío; Rigolin, Gian Matteo; Bonfiglio, Silvia; Scarfo, Lydia; Mattsson, Mattias; Davis, Zadie; Gogia, Ajay; Rani, Lata; Baliakas, Panagiotis; Foroughi-Asl, Hassan; Jylhä, Cecilia; Skaftason, Aron; Rapado, Inmaculada; Miras, Fatima; Martinez-Lopez, Joaquín; de la Serna, Javier; Rivas, Jesús María Hernández; Thornton, Patrick; Larráyoz, María José; Calasanz, María José; Fésüs, Viktória; Mátrai, Zoltán; Bödör, Csaba; Smedby, Karin E; Espinet, Blanca; Puiggros, Anna; Gupta, Ritu; Bullinger, Lars; Bosch, Francesc; Tazón-Vega, Bárbara; Baran-Marszak, Fanny; Oscier, David; Nguyen-Khac, Florence; Zenz, Thorsten; Terol, Maria Jose.
Afiliação
  • Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.
  • Meggendorfer M; Department of Mathematics, University of Ioannina, Ioannina, Greece.
  • Parker H; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Nadeu F; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Brieghel C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Laidou S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Moia R; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Rossi D; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.
  • Catherwood M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
  • Kotaskova J; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Delgado J; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Rodríguez-Vicente AE; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Benito R; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Rigolin GM; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Bonfiglio S; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Scarfo L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Mattsson M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Davis Z; Hospital Clínic of Barcelona, Barcelona, Spain.
  • Gogia A; Universitat de Barcelona, Barcelona, Spain.
  • Rani L; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.
  • Baliakas P; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.
  • Foroughi-Asl H; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
  • Jylhä C; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.
  • Skaftason A; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.
  • Rapado I; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
  • Miras F; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Martinez-Lopez J; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
  • de la Serna J; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
  • Rivas JMH; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Thornton P; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK.
  • Larráyoz MJ; All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Calasanz MJ; All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Fésüs V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Mátrai Z; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Bödör C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Smedby KE; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Espinet B; Hospital Universitario 12 Octubre, Madrid, Spain.
  • Puiggros A; Spanish National Cancer Research (CNIO), Madrid, Spain.
  • Gupta R; Hospital Universitario 12 Octubre, Madrid, Spain.
  • Bullinger L; Hospital Universitario 12 Octubre, Madrid, Spain.
  • Bosch F; Spanish National Cancer Research (CNIO), Madrid, Spain.
  • Tazón-Vega B; Hospital Universitario 12 Octubre, Madrid, Spain.
  • Baran-Marszak F; Spanish National Cancer Research (CNIO), Madrid, Spain.
  • Oscier D; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.
  • Nguyen-Khac F; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.
  • Zenz T; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
  • Terol MJ; Haematology Department, Beaumont Hospital, Dublin, Ireland.
Leukemia ; 37(2): 339-347, 2023 02.
Article em En | MEDLINE | ID: mdl-36566271
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia